Merck Tbk PT

Merck Tbk PT Gross Margin

The Gross Margin of Merck Tbk PT (MERK.JK) as of Nov 5, 2026 is 46.84 %. In the previous year, Gross Margin was 38.84 % — a change of 20.61% (higher).

Gross Margin

46.84 %

YoY

20.61%

Last updated:

Gross Margin of Merck Tbk PT is 2025 46.84 % . Gross Margin of Merck Tbk PT was 2024 38.84 % . It decreases by 20.61% higher compared to the previous year.

For Merck Tbk PT, the gross margin of 46.8% is up versus 37.5% a few years ago.

The Merck Tbk PT Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
34.59 IDR
Jan 1, 2019
43.42 IDR
Jan 1, 2020
44.86 IDR
Jan 1, 2021
37.46 IDR
Jan 1, 2022
38.02 IDR
Jan 1, 2023
41.65 IDR
Jan 1, 2024
38.84 IDR
Jan 1, 2025
46.84 IDR
The Merck Tbk PT Gross Margin history
YEARGross MarginYoY
46.84 %+20.61%
38.84 %-6.76%
41.65 %+9.55%
38.02 %+1.51%
37.46 %-16.50%
44.86 %+3.32%
43.42 %+25.52%
34.59 %-31.95%
50.84 %-2.98%
52.40 %+3.83%
50.46 %-4.99%
53.11 %+11,524.92%
0.46 %+0.09%
0.46 %-13.04%
0.52 %-5.50%
0.56 %-4.63%
0.58 %+2.66%
0.57 %-2.44%
0.58 %-0.44%
0.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT generates revenue through its Biopharma segment, which focuses on ethical pharmaceutical products for serious diseases. The company also earns from Consumer Health, offering over-the-counter products that support personal wellness and family planning needs. Its 'Others' segment includes additional business activities. The firm serves healthcare providers, pharmacies, and individual consumers seeking personalized treatments and accessible health solutions. Biopharma targets medical professionals and hospitals with specialized treatments for critical conditions. Consumer Health products are sold directly to consumers through retail channels for daily health management. The company's business model relies on delivering tailored healthcare solutions across its three operational segments to meet diverse market demands. Merck Tbk PT's revenue streams are structured around pharmaceutical innovations and consumer health products. Ethical products in Biopharma address unmet medical needs, while over-the-counter offerings in Consumer Health cater to everyday health requirements. The firm's focus on personalized care ensures consistent demand from both professional and individual customers. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

Gross Margin of Merck Tbk PT is 46.84 % in 2025.

Gross Margin of Merck Tbk PT changed from 38.84 % to 46.84 %, representing a 20.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Merck Tbk PT with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Merck Tbk PT

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Merck Tbk PT